183 related articles for article (PubMed ID: 12692596)
1. Single dose of a vaccine based on DNA encoding mycobacterial hsp65 protein plus TDM-loaded PLGA microspheres protects mice against a virulent strain of Mycobacterium tuberculosis.
Lima KM; Santos SA; Lima VM; Coelho-Castelo AA; Rodrigues JM; Silva CL
Gene Ther; 2003 Apr; 10(8):678-85. PubMed ID: 12692596
[TBL] [Abstract][Full Text] [Related]
2. Combined DNA vaccine encapsulated in microspheres enhanced protection efficacy against Mycobacterium tuberculosis infection of mice.
Cai H; Hu XD; Yu DH; Li SX; Tian X; Zhu YX
Vaccine; 2005 Jul; 23(32):4167-74. PubMed ID: 15908060
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
Changhong S; Hai Z; Limei W; Jiaze A; Li X; Tingfen Z; Zhikai X; Yong Z
Tuberculosis (Edinb); 2009 Jan; 89(1):54-61. PubMed ID: 19056317
[TBL] [Abstract][Full Text] [Related]
4. DNA vaccine using hemagglutinating virus of Japan-liposome encapsulating combination encoding mycobacterial heat shock protein 65 and interleukin-12 confers protection against Mycobacterium tuberculosis by T cell activation.
Yoshida S; Tanaka T; Kita Y; Kuwayama S; Kanamaru N; Muraki Y; Hashimoto S; Inoue Y; Sakatani M; Kobayashi E; Kaneda Y; Okada M
Vaccine; 2006 Feb; 24(8):1191-204. PubMed ID: 16216394
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and protective efficacy of a DNA vaccine encoding the fusion protein of mycobacterium heat shock protein 65 (Hsp65) with human interleukin-2 against Mycobacterium tuberculosis in BALB/c mice.
Wang LM; Bai YL; Shi CH; Gao H; Xue Y; Jiang H; Xu ZK
APMIS; 2008 Dec; 116(12):1071-81. PubMed ID: 19133010
[TBL] [Abstract][Full Text] [Related]
6. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
7. Mycobacterium hsp65 DNA entrapped into TDM-loaded PLGA microspheres induces protection in mice against Leishmania (Leishmania) major infection.
Coelho EA; Tavares CA; Lima Kde M; Silva CL; Rodrigues JM; Fernandes AP
Parasitol Res; 2006 May; 98(6):568-75. PubMed ID: 16432754
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice.
Bivas-Benita M; Lin MY; Bal SM; van Meijgaarden KE; Franken KL; Friggen AH; Junginger HE; Borchard G; Klein MR; Ottenhoff TH
Vaccine; 2009 Jun; 27(30):4010-7. PubMed ID: 19389445
[TBL] [Abstract][Full Text] [Related]
9. Vaccine adjuvant: it makes the difference.
Lima KM; dos Santos SA; Rodrigues JM; Silva CL
Vaccine; 2004 Jun; 22(19):2374-9. PubMed ID: 15193397
[TBL] [Abstract][Full Text] [Related]
10. A subunit vaccine based on biodegradable microspheres carrying rHsp65 protein and KLK protects BALB/c mice against tuberculosis infection.
dos Santos SA; Zárate-Bladés CR; de Sá Galetti FC; Brandão IT; Masson AP; Soares EG; Araújo AP; Silva CL
Hum Vaccin; 2010 Dec; 6(12):1047-53. PubMed ID: 21157178
[TBL] [Abstract][Full Text] [Related]
11. Prime-boost vaccination based on DNA and protein-loaded microspheres for tuberculosis prevention.
Ruberti M; De Melo LK; Dos Santos SA; Brandao IT; Soares EG; Silva CL; Júnior JM
J Drug Target; 2004 May; 12(4):195-203. PubMed ID: 15506168
[TBL] [Abstract][Full Text] [Related]
12. Cell-mediated immune responses and protective efficacy against infection with Mycobacterium tuberculosis induced by Hsp65 and hIL-2 fusion protein in mice.
Shi C; Yuan S; Zhang H; Zhang T; Wang L; Xu Z
Scand J Immunol; 2009 Feb; 69(2):140-9. PubMed ID: 19144078
[TBL] [Abstract][Full Text] [Related]
13. DNA vaccine encoding ESAT-6 enhances the protective efficacy of BCG against Mycobacterium tuberculosis infection in mice.
Fan X; Gao Q; Fu R
Scand J Immunol; 2007 Nov; 66(5):523-8. PubMed ID: 17916110
[TBL] [Abstract][Full Text] [Related]
14. Improved efficacy of DNA vaccination against breast cancer by boosting with the repeat beta-hCG C-terminal peptide carried by mycobacterial heat-shock protein HSP65.
Yi H; Rong Y; Yankai Z; Wentao L; Hongxia Z; Jie W; Rongyue C; Taiming L; Jingjing L
Vaccine; 2006 Mar; 24(14):2575-84. PubMed ID: 16420967
[TBL] [Abstract][Full Text] [Related]
15. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
16. A new vaccine against tuberculosis shows greater protection in a mouse model with progressive pulmonary tuberculosis.
Castañon-Arreola M; López-Vidal Y; Espitia-Pinzón C; Hernández-Pando R
Tuberculosis (Edinb); 2005; 85(1-2):115-26. PubMed ID: 15687035
[TBL] [Abstract][Full Text] [Related]
17. Effect of hsp65 DNA vaccination carrying immunostimulatory DNA sequences (CpG motifs) against Mycobacterium leprae multiplication in mice.
Nomaguchi H; Mukai T; Takeshita F; Matsuoka M; Maeda Y; Aye TM; Jahan N; Yogi Y; Endo M; Sato Y
Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):182-90. PubMed ID: 12483966
[TBL] [Abstract][Full Text] [Related]
18. [Construction of the fusion gene of Hsp65 of Mycobacterium tuberculosis and EGFP and preparation of dendritic cell vaccine against tuberculosis].
Xiao L; Wei YZ; Xia F; Liu SW
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jan; 21(1):13-6. PubMed ID: 15629074
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a novel vaccine (HVJ-liposome/HSP65 DNA+IL-12 DNA) against tuberculosis using the cynomolgus monkey model of TB.
Okada M; Kita Y; Nakajima T; Kanamaru N; Hashimoto S; Nagasawa T; Kaneda Y; Yoshida S; Nishida Y; Fukamizu R; Tsunai Y; Inoue R; Nakatani H; Namie Y; Yamada J; Takao K; Asai R; Asaki R; Matsumoto M; McMurray DN; Dela Cruz EC; Tan EV; Abalos RM; Burgos JA; Gelber R; Sakatani M
Vaccine; 2007 Apr; 25(16):2990-3. PubMed ID: 17280753
[TBL] [Abstract][Full Text] [Related]
20. Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus monkey model.
Kita Y; Tanaka T; Yoshida S; Ohara N; Kaneda Y; Kuwayama S; Muraki Y; Kanamaru N; Hashimoto S; Takai H; Okada C; Fukunaga Y; Sakaguchi Y; Furukawa I; Yamada K; Inoue Y; Takemoto Y; Naito M; Yamada T; Matsumoto M; McMurray DN; Cruz EC; Tan EV; Abalos RM; Burgos JA; Gelber R; Skeiky Y; Reed S; Sakatani M; Okada M
Vaccine; 2005 Mar; 23(17-18):2132-5. PubMed ID: 15755583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
